Renal amyloidosis: new perspectives

  • Dorothea Zucker-Franklin
Part of the Developments in Nephrology book series (DINE, volume 22)


It has been recognized for more than 100 years that some forms of renal disease are associated with, or even due to, amyloidosis. Early papers merely described deposits of amorphous eosinophilic material. After Congo Red was introduced as a stain for amyloid, many reports appeared of the type exemplified by the publication of Heptinstall and Joekes [1] who, on studying the kidneys of patients with rheumatoid arthritis, were intrigued by finding amyloid primarily in the glomerular tufts and the basement membrane with little tubular involvement until late in disease. These descriptions were followed by the application of ultrastructural techniques and the discovery that amyloid is fibrillar [2–6]. In the kidney, such fibrils are seen in the region referred to as the mesangium, in close proximity to endo- and epithelial cells as well as within the basal lamina, particulary where they are thickened (Figs 1A and B). During the past two decades, when it became clear that amyloid may represent many different precursor proteins, it has even become possible to define the type of amyloid protein deposited in the kidney with the help of specific antisera which can be used on the light as well as on the electron microscopic level.


Familial Mediterranean Fever Carpal Tunnel Syndrome Mesangial Cell Amyloid Fibril Amyloid Formation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Heptinstall RH, Joekes AM. Renal amyloid. Annals of Rheum Dis 1960; 19: 126–34.CrossRefGoogle Scholar
  2. 2.
    Pras M, Zucker-Franklin D, Rimon A, Franklin EC. Physical, chemical and ultrastructural studies of water-soluble human amyloid fibrils. J Exp Med 1969; 130: 777–95.PubMedCrossRefGoogle Scholar
  3. 3.
    Shirahama T, Cohen AS. High-resolution electron microscopic analysis of the amyloid fibril. J Cell Biol 1967; 33: 679–708.PubMedCrossRefGoogle Scholar
  4. 4.
    Shirahama T, Cohen AS. Fine structure of the glomerulus in human and experimental renal amyloidosis. Am J Path 1967; 51: 869–911.PubMedGoogle Scholar
  5. 5.
    Pras M, Schubert M, Zucker-Franklin D, Rimon A, Franklin EC. The characterization of soluble amyloid prepared in water. J Clin Invest 1968; 47: 924–33.PubMedCrossRefGoogle Scholar
  6. 6.
    Jao W, Pirani CL. Renal amyloidosis: Electron microscopic observations. Acta Path Microbiol Scand 80 Supplement 1972; 233: 217–27.Google Scholar
  7. 7.
    Glenner GG, Terry W, Harada M, Isersky C, Page D. Amyloid fibril proteins: Proof of homology wiht immunoglobulin light chains by sequence analysis. Science 1971; 172: 1150–1.PubMedCrossRefGoogle Scholar
  8. 8.
    Linke RP, Zucker-Franklin D, Franklin EC. Morphologic, chemical and immunologic studies of amyloid-like fibrils formed from Bence-Jones proteins by proteolysis. J Immunol 1973; 111: 10–23.PubMedGoogle Scholar
  9. 9.
    Franklin EC, Zucker-Franklin D. Current concepts of amyloid. Advances in Immunol 1972; 15:249–304.CrossRefGoogle Scholar
  10. 10.
    Teilum G. Amyloidosis secondary to agammaglobulenemia. J Path Bact 1964; 88: 317–20.PubMedCrossRefGoogle Scholar
  11. 11.
    Levin M, Franklin EC, Frangione B, Pras M. The amino acid sequence of a major non-immunoglobulin component of some amyloid fibrils. J Clin Invest 1972; 51: 2773–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Ericksen N, Ericksson LH, Pearsall N, Lagunoff D, Benditt EP. Mouse amyloid protein AA: Homology with non-immunoglobulin proteins of human and monkey amyloid substance. Proc Natl Acad of Sciences 1976; 73: 964–7.CrossRefGoogle Scholar
  13. 13.
    Westermark P, Natvig JB, Anders RF, Sletten K, Husby G. Coexistence of protein AAand immunoglobulin light-chain fragments in amyloid fibrils. Scan J of Immunol 1976; 5:31–6.CrossRefGoogle Scholar
  14. 14.
    Gallo GR, Feiner HD, Chuba JV, Beneck D, Marion P, Cohen DH. Characterization of tissue amyloid by immunoflorescence microscopy. Clin Immunol and Immunopath 1986; 39: 479–90.CrossRefGoogle Scholar
  15. 15.
    Karlsson FA, Wibell L, Evrin PE. β 2-microglobulin in clinical medicine. Scan J Clin Lab Invest Supplement 154 1980; 40: 27–37.Google Scholar
  16. 16.
    Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitomo T, Kastaoka H, Suzuki M, Hirasawa Y, Shirahama T, Cohen AS, Schmid K. A new form of amyloid associated with chronic hemodialysis was identified as β 2-microglobulin. Biochem and Biophys Res. Comm. 1985; 129: 701–6.Google Scholar
  17. 17.
    Shirahama T, Skinner M, Cohen AS, Gejyo F, Arakawa M, Suzuki M, Hirasawa Y. Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as β 2-microglobulin. Lab Invest 1985; 53: 705–9.PubMedGoogle Scholar
  18. 18.
    Gorevic PD, Munoz PC, Casey TT, DiRaimondo CR, Stone WJ, Prelli FC, Rodrigues MM. Poulik MD, Frangione B. Polymerization of intact β 2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis. Proc Natl Acad Sci USA 1986; 83:7908–12.PubMedCrossRefGoogle Scholar
  19. 19.
    Zucker-Franklin D. Immunophagocytosis of human amyloid fibrils by leukocytes. J Ultrastructure Res 1970; 32: 247–57.CrossRefGoogle Scholar
  20. 20.
    Glenner GG, Eanes ED, Bladen HA, Linke RP, Thermine JD.β-pleated sheet fibrils: a comparison of native amyloid with synthetic protein fibrils. J Histochem and Cytochem 1974; 22: 1141–58.CrossRefGoogle Scholar
  21. 21.
    Shirahama T, Cohen AS. Intralysosomal formation of amyloid fibrils. Am J Path 1975: 81: 101–16.PubMedGoogle Scholar
  22. 22.
    Castaño EM, Ghiso J, Prelli F, Gorevic PD, Migheli A, Frangione B. In vitro formation of amyloid fibrils from synthetic peptides of different lengths homologous to Alzheimer’s disease β 2-protein. Biochem Biophys Res Comm 1986; 141: 782–89.PubMedCrossRefGoogle Scholar
  23. 23.
    Fuks A, Zucker-Franklin D. Impaired Kupffer cell function precedes development of secondary amyloidosis. J Exp Med 1985; 161: 1013–28.PubMedCrossRefGoogle Scholar
  24. 24.
    Farquhar MG, Palade GE. Functional evidence for the existence of a third cell type in the renal glomerulus. J. Cell Biol 1962; 13: 55–87.PubMedCrossRefGoogle Scholar
  25. 25.
    Lavie G, Zucker-Franklin D, Franklin EC. Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes. J Exp Med 1978; 148: 1020–31.PubMedCrossRefGoogle Scholar
  26. 26.
    Lavie G, Franklin EC, Zucker-Franklin D. Elastase-type proteases on the surface of human blood monocytes: Possible role in amyloid formation. J Immunol 1980; 125: 175–80.PubMedGoogle Scholar
  27. 27.
    Rosenthal CJ, Franklin EC, Frangione B, Greenspan J. Isolation and partial characterization of SAA — An amyloid related protein from human serum. J Immunol 1976; 116: 1415–8.PubMedGoogle Scholar
  28. 28.
    Cohn ZA. The activation of mononuclear phagocytes: Fact, fancy and future. J Immunol 1978; 121: 813–6.PubMedGoogle Scholar
  29. 29.
    Zucker-Franklin D, Lavie G, Franklin EC. Demonstration of membrane-bound proteolytic activity on the surface of mononuclear leukocytes. J of Histochem and Cytochem 1981; 29: 451–6.CrossRefGoogle Scholar
  30. 30.
    Fuks A, Zucker-Franklin D, Franklin EC. Identification of elastases associated with purified plasma membranes isolated from human monocytes and lymphocytes. Biochimica et Biophysica Acta 1983; 755: 195–203.PubMedGoogle Scholar
  31. 31.
    Warfel AH, Zucker-Franklin D. Down-regulation of macrophage lysozyme by lipopolysaccharide and interferon. J Immunol 1986; 137: 651–5.PubMedGoogle Scholar
  32. 32.
    Lowenstein J, Gallo G. Remission of the nephrotic syndrome in renal amyloidosis. New Eng J Med 1970; 282: 128–32.CrossRefGoogle Scholar
  33. 33.
    Dikman SH, Kahn T, Gribetz D, Churg J. Resolution of renal amyloidosis. Am J Med 1977;63:430–3.PubMedCrossRefGoogle Scholar
  34. 34.
    Zemer D, Pras M, Sohar E, Modan M, Cabill S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. New Engl J Med 1986;314:1001–10.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers, Dordrecht 1988

Authors and Affiliations

  • Dorothea Zucker-Franklin
    • 1
  1. 1.University Hospital, Room 445, Department of MedicineNew York University Medical CenterNew YorkUSA

Personalised recommendations